Incyte Corp (INCY)
57.10
+0.24
(+0.42%)
USD |
NASDAQ |
May 17, 16:00
57.07
-0.03
(-0.05%)
After-Hours: 20:00
Incyte Price to Book Value: 2.377 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 2.377 |
| May 16, 2024 | 2.367 |
| May 15, 2024 | 2.375 |
| May 14, 2024 | 2.375 |
| May 13, 2024 | 2.398 |
| May 10, 2024 | 2.209 |
| May 09, 2024 | 2.227 |
| May 08, 2024 | 2.227 |
| May 07, 2024 | 2.263 |
| May 06, 2024 | 2.251 |
| May 03, 2024 | 2.238 |
| May 02, 2024 | 2.210 |
| May 01, 2024 | 2.204 |
| April 30, 2024 | 2.167 |
| April 29, 2024 | 2.188 |
| April 26, 2024 | 2.151 |
| April 25, 2024 | 2.130 |
| April 24, 2024 | 2.154 |
| April 23, 2024 | 2.15 |
| April 22, 2024 | 2.161 |
| April 19, 2024 | 2.179 |
| April 18, 2024 | 2.199 |
| April 17, 2024 | 2.194 |
| April 16, 2024 | 2.215 |
| April 15, 2024 | 2.224 |
| Date | Value |
|---|---|
| April 12, 2024 | 2.242 |
| April 11, 2024 | 2.286 |
| April 10, 2024 | 2.289 |
| April 09, 2024 | 2.302 |
| April 08, 2024 | 2.291 |
| April 05, 2024 | 2.299 |
| April 04, 2024 | 2.289 |
| April 03, 2024 | 2.302 |
| April 02, 2024 | 2.324 |
| April 01, 2024 | 2.358 |
| March 31, 2024 | |
| March 28, 2024 | 2.465 |
| March 27, 2024 | 2.471 |
| March 26, 2024 | 2.446 |
| March 25, 2024 | 2.487 |
| March 22, 2024 | 2.465 |
| March 21, 2024 | 2.497 |
| March 20, 2024 | 2.520 |
| March 19, 2024 | 2.524 |
| March 18, 2024 | 2.481 |
| March 15, 2024 | 2.525 |
| March 14, 2024 | 2.533 |
| March 13, 2024 | 2.549 |
| March 12, 2024 | 2.567 |
| March 11, 2024 | 2.630 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.130
Minimum
Apr 25 2024
12.22
Maximum
Jun 22 2020
5.551
Average
4.680
Median
Mar 29 2022
Price to Book Value Benchmarks
| Walgreens Boots Alliance Inc | 1.163 |
| Illumina Inc | 3.086 |
| Pfizer Inc | 1.759 |
| Bristol-Myers Squibb Co | 5.413 |
| Syndax Pharmaceuticals Inc | 3.506 |
Price to Book Value Related Metrics
| PE Ratio | 17.30 |
| PS Ratio | 3.430 |
| PEG Ratio | 0.1356 |
| Price to Free Cash Flow | 16.35 |
| Price | 57.10 |
| Earnings Yield | 5.78% |
| Market Cap | 12.82B |
| PEGY Ratio | 0.1356 |
| Operating PE Ratio | 18.20 |
| Normalized PE Ratio | 19.71 |